The Motley Fool

Why Shares Just Got Better

Older investors withdrew nearly £3bn from savings accounts in the past 12 months, according to research from Aviva. The over-55s have reduced their average cash savings by 10%, disillusioned with interest rates that don’t keep pace with inflation, and instead have turned to higher-risk investments such as equities and corporate bonds.

Good news

That’s good news for shares that are typically found in equity income funds and which sensibly form the cornerstone of any portfolio: solid, dependable companies such as drugs giant GlaxoSmithKline (LSE: GSK)(NYSE: GSK.US) and consumer goods firm Unilever (LSE: ULVR)(NYSE: UL.US).

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

In the past, investors have tended to shift their investments away from risk assets and into cash as they get older. The worry has been that baby-boomers, whose investments have fuelled the stock exchange, would start to withdraw from equities and create a drag on stock prices.

New normal

But if those investors learn a new habit — to stay invested, but in safer equities — then it boosts the long-term prospects for such shares. With the new Bank of England Governor suggesting interest rates will remain low for another three years, while taking a relaxed attitude to inflation, remaining invested into old age could become the new normal.

Of course, we all know that shares can go down as well as up. Older investors require less volatility, so a good spread of relatively safe shares is essential.

Defensive

That means shares such as GSK. Pharmaceuticals is a classic defensive — i.e. less volatile — sector. Big pharma companies have wrestled with the loss of patents on older blockbuster drugs but GSK is now coming out the other side, with its massive R&D spend creating a strong pipeline of new drugs. Turnover is expected to start climbing again this year.

What’s more, GSK has diversified into less risky vaccines and over-the-counter medicines, and made a big push into emerging markets. It’s currently embroiled in a corruption scandal in China, but that hasn’t hurt the share price.

Unilever is also in a defensive sector, and its strong global brands and scale give it immense market power. It’s the third-largest consumer goods firm in the world, but the best established in emerging markets. A heritage in the former British and Dutch colonies gave it an early foothold. They now account for nearly 60% of sales and are powering growth.

Unilever’s shares are down 12% from their recent all-time high, and it could be a good time to stock up.

Yield

GSK and Unilever yield 4.6% and 3.6% respectively. That’s far better than a savings account, even before any prospects for capital growth.

If you are looking for other shares that are suitable for long-term investment, I suggest you read ‘Five Shares to Retire on’. It’s an exclusive report from the Motley Fool that describes other cornerstone shares, including one yielding well over 5%. That’s a great antidote to high inflation and low interest rates. You can download the report by clicking here — it’s free.

> Tony owns shares in GSK, Unilever and Aviva. The Motley Fool has recommended shares in GSK and Unilever.

“This Stock Could Be Like Buying Amazon in 1997”

I'm sure you'll agree that's quite the statement from Motley Fool Co-Founder Tom Gardner.

But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.

What's more, we firmly believe there's still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.

And right now, we're giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool.

Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge!

Our 6 'Best Buys Now' Shares

The renowned analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply enter your email address below to discover how you can take advantage of this.

I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement.